# GE Healthcare Inc., Arlington Heights, IL – FDA Inspections

Source: https://www.keypedia.com/companies/ge-healthcare-inc/b959f09c-3de8-449e-bed3-d919c59edf59

> Inspection records and compliance data for GE Healthcare Inc. in Arlington Heights, Illinois. 10 FDA inspections on record, last inspected September 19, 2025.

---

## Details

- Name: GE Healthcare Inc.
- FEI Number: 1417338
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, PACK, REPACK
- Address Line 1: 3350 N Ridge Ave
- City: Arlington Heights
- State: Illinois
- Zip Code: 60004
- Country Name: United States
- Address: 3350 N Ridge Ave, Arlington Heights, Illinois 60004, United States
- Country: United States

## Related Documents

- FDA Inspection 1287530 - GE Healthcare Inc. - 2025-09-19 — source: FDA, date: September 19, 2025
- FDA Inspection 1287530 - GE Healthcare Inc. - 2025-09-19 — classification: No Action Indicated (NAI), source: FDA, date: September 19, 2025
- [FDA Inspection 1232232 - GE Healthcare Inc. - 2024-03-08](https://www.keypedia.com/records/fda_inspections/ge-healthcare-inc/ab3eaa59-c633-46ea-8be0-e091bbd9031c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 8, 2024
- FDA Inspection 1221712 - GE Healthcare Inc. - 2023-10-02 — source: FDA, date: October 2, 2023
- FDA Inspection 1117219 - GE Healthcare Inc. - 2020-01-24 — classification: No Action Indicated (NAI), source: FDA, date: January 24, 2020
- FDA Inspection 1026911 - GE Healthcare Inc. - 2017-09-06 — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2017
- FDA Inspection 916324 - GE Healthcare Inc. - 2015-03-05 — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2015
- FDA Inspection 916324 - GE Healthcare Inc. - 2015-03-05 — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2015
- FDA Inspection 838003 - GE Healthcare Inc. - 2013-07-09 — classification: No Action Indicated (NAI), source: FDA, date: July 9, 2013
- FDA Inspection 838003 - GE Healthcare Inc. - 2013-07-09 — classification: No Action Indicated (NAI), source: FDA, date: July 9, 2013

## Related Companies

- [Bio-Technology General (Israel), Ltd.](https://www.keypedia.com/companies/bio-technology-general-israel-ltd/7e4f2eb9-bacb-4307-9003-5a223c16eed8)
- [Sanofi-Aventis Deutschland GmbH](https://www.keypedia.com/companies/sanofi-aventis-deutschland-gmbh/07c96432-bb43-45e5-a80d-e4bca284dbab)
- [Abbvie SRL](https://www.keypedia.com/companies/abbvie-srl/18de4b46-e9fa-4a25-98cf-7d4522f49d66)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Roche Diagnostics GmbH](https://www.keypedia.com/companies/roche-diagnostics-gmbh/a23249df-90f8-49fa-8a07-267a69157488)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)
- [McDermott Laboratories Ltd. trading as Mylan Dublin Respiratory](https://www.keypedia.com/companies/mcdermott-laboratories-ltd-trading-as-mylan-dublin-respiratory/89f4e5b2-91ef-45d6-80c9-d9cbf732d5e8)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [The Procter & Gamble Manufacturing Company](https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/c23efaf8-7ca9-487e-8673-c7ba4ae59e53)